Tumor Necrosis Factor-&Agr;: a Key Contributor to Intervertebral Disc Degeneration

Cheng Wang,Xiaohua Yu,Yiguo Yan,Wei Yang,Shujun Zhang,Yongxiao Xiang,Jian Zhang,Wenjun Wang
DOI: https://doi.org/10.1093/abbs/gmw112
IF: 3.7
2016-01-01
Acta Biochimica et Biophysica Sinica
Abstract:Intervertebral disc (IVD) degeneration (IDD) is the most common cause leading to low back pain (LBP), which is a highly prevalent, costly, and crippling condition worldwide. Current treatments for IDD are limited to treat the symptoms and do not target the pathophysiology. Tumor necrosis factor-α (TNF-α) is one of the most potent pro-inflammatory cytokines and signals through its receptors TNFR1 and TNFR2. TNF-α is highly expressed in degenerative IVD tissues, and it is deeply involved in multiple pathological processes of disc degeneration, including matrix destruction, inflammatory responses, apoptosis, autophagy, and cell proliferation. Importantly, anti-TNF-α therapy has shown promise for mitigating disc degeneration and relieving LBP. In this review, following a brief description of TNF-α signal transduction, we mainly focus on the expression pattern and roles of TNF-α in IDD, and summarize the emerging progress regarding its inhibition as a promising biological therapeutic approach to disc degeneration and associated LBP. A better understanding will help to develop novel TNF-α-centered therapeutic interventions for degenerative disc disease.
What problem does this paper attempt to address?